JSPR Stock Analysis: Buy, Sell, or Hold?
JSPR - Jasper Therapeutics, Inc. Common Stock
$0.53
-0.02 (-3.45%)
▼
5d:
-41.01%
30d:
-46.0%
90d:
-62.51%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When JSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called JSPR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: JSPR is down 41.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: JSPR is down 41.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: JSPR is currently trading at $0.53, which is considered oversold relative to its 30-day fair value range of $0.74 to $0.99.
Technical Outlook: Technically, JSPR is in a strong downtrend. Immediate support is located at $0.43, while resistance sits at $1.02. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+1309.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JSPR is in a strong downtrend. Immediate support is located at $0.43, while resistance sits at $1.02. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.50 (+1309.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.74 -
$0.99
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 1309.0% below Wall St target ($7.50)
- WARNING: Recommendation downgraded due to -41.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.74 -
$0.99
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.43
Resistance Level
$1.02
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.29
Wall Street Target
$7.50
(+1309.0%)
Share & Embed Analysis
Last updated: June 03, 2026 7:50 PM ET
Data refreshes hourly during market hours. Next update: 8:50 PM
Data refreshes hourly during market hours. Next update: 8:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 59 HOLD |
